SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-006142
Filing Date
2022-03-07
Accepted
2022-03-07 08:15:26
Documents
14
Period of Report
2022-03-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39771
2 ex99-1.htm EX-99.1 58322
3 ex99-1_001.jpg GRAPHIC 8908
  Complete submission text file 0001493152-22-006142.txt   292849

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rspi-20220307.xsd EX-101.SCH 3036
5 XBRL LABEL FILE rspi-20220307_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE rspi-20220307_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 22716329
SIC: 2834 Pharmaceutical Preparations